FDA Investigator Raihan A Chowdhury
Raihan A Chowdhury has conducted inspections on 11 sites in 1 countries as of 13 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
11
Last Inspection Date:
13 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Raihan A Chowdhury:
Adena S Yau,
Alberto A Viciedo,
Alice S Tsao,
Althea A Williams,
Amatul H Marium,
Anastasia M Shields,
Andrew J Garufi,
Arduino Frankovic,
Barbara J Maulfair,
Bijoy Panicker,
Brandy N Lepage,
Charisse K Green,
Clifton C Francis,
Daniel J Grabicki,
David R Delucia,
Deborah B Nixon,
Demitria J Xiradakis,
Dennis E Guilfoyle, PhD,
Dongping Dai, PhD,
Dr. Robert C Horan, MD,
Felix Maldonado,
Gam S Zamil,
Gary J Lehr,
George J Flynn,
Guerlain Ulysse,
Harshal J Desai,
James A Liubicich,
Jennifer L Huntington,
Jonathan G Matrisciano,
Jose Ohernandez Guzman,
Jose Velez,
Joseph F Mcginnis, RPh,
Jung K Kim,
Karen E D'orazio,
Karishma G Gopaul,
Kenneth H Williams,
Kim Lthomas Cruse,
Kinh Q Mac,
Kwong P Lee,
Lawrence W Farina,
Li Li,
Luxuly Abraham,
Martrice A Packer,
Marvin D Jones,
Meredith P Soehl, Investigator,
Michael O Idowu,
Mindy M Chou,
Neil J Bonzagni, PhD MPH,
Parul M Patel,
Paul Mouris,
Peter Abel,
Peter Caparelli,
Peter R Caparelli,
Rachael A Moliver,
Robert C Steyert,
Robert J Maffei,
Rochelle K Kimmel,
Ronald Ifraimov,
Samantha J Bradley,
Saundrea A Munroe,
Shelton L Stribling,
Sony Mathews,
Steven D Dittert,
Tanya R Syffrard,
Tara G Bizjak,
Tara R Gooen,
Terry Bridgewater,
Tonia F Bernard,
Uduak M Inokon,
Vivin George,
Zada L Giles
Raihan A Chowdhury's Documents
Publish Date | Document Type | Title |
---|---|---|
June, 2023 | FDA 483 | Amware Fulfillment - Form 483, 2023-06-22 |
February, 2023 | FDA 483 | HomeoCare Laboratories Inc. - Form 483, 2023-02-21 |
April, 2023 | FDA 483 | Netech Corp. - Form 483, 2023-04-14 |
January, 2024 | FDA 483 | Pharmalogic New York City, LLC - Form 483, 2024-01-12 |
March, 2024 | FDA 483 | Island Testing and Tech Services LLC - Form 483, 2024-03-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more